Biotechnology, CAR - T Cell therapy, CAR T-Cell, CAR therapy, China, fund raise, Oricell Therapeutics
Oricell raises additional $45M USD to expand its CAR T-Cell therapy to United States
23rd March 2023: The preclinical and early-stage cancer cell therapies being developed by Shanghai biotech Oricell have received an additional $45 million in funding, the company announced on Tuesday. Following a showing at AS..
Beijing, Biotechnology, Cell therapy, Cellular therapy, China, Cilta-Cel, ciltacabtagene autoleucel, Legend biotech
Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China
SOMERSET, N.J.—JANUARY 2, 2023— Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, ann..